Apparel Brand Allbirds Prices US$303 Million IPO

Footwear and apparel brand Allbirds, Inc. (Nasdaq: BIRD) started trading on the Nasdaq Global Select Market today while also announcing pricing for their IPO. The firm aims to raise US$302.9 million in its debut on the big board.

The offering consisted of 20,192,307 Class A common shares at US$15.00 per share. Out of this, 16,346,154 shares will be sold by the company while the remaining 3,846,153 shares will be sold by existing stockholders. The company’s shares will be trading on the Nasdaq exchange under the ticker symbol “BIRD”.

Morgan Stanley, J.P. Morgan, and BofA Securities are acting as the lead bookrunners for the said offering. The offering is expected to close on November 5, 2021, subject to customary closing conditions.

The California-headquartered lifestyle brand has New Zealand roots in the material it uses for its apparel, merino wool.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

First Majestic Posts Record Cash Flows In Q1 As Production Costs Fall

Brazil Potash Secures Funding In Support Of US$2.5 Billion Autozales Project

Related News

Robinhood’s IPO to be Priced at $38 Per Share

Robinhood’s IPO is expected to hit the Nasdaq today, but it appears that unenthusiastic demand...

Thursday, July 29, 2021, 09:00:00 AM

Robinhood Covertly Files for US IPO

Fresh from its discomfiting Congressional hearing and onslaught of scrutiny from retail trading fanatics over...

Wednesday, March 24, 2021, 09:42:00 AM

Biopharmaceutical Firm Candel Therapeutics Prices Downsized US$72 Million IPO

Late clinical stage biopharmaceutical company Candel Therapeutics Inc. (Nasdaq: CADL) started publicly trading on the...

Tuesday, July 27, 2021, 10:47:00 AM

Biotech Firm IN8bio Eyes US$40 Million IPO

Clinical-stage biopharmaceutical company IN8bio, Inc. (Nasdaq: INAB) began trading on the Nasdaq Global Market today...

Friday, July 30, 2021, 11:56:00 AM

Biotech Firm HilleVax Prices US$200 Million IPO

Biopharmaceutical company HilleVax, Inc. (Nasdaq: HLVX) began trading on the Nasdaq Global Select Market on...

Monday, May 2, 2022, 02:25:00 PM